Liver Diseases  >>  mycophenolate mofetil  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mycophenolate mofetil / Generic mfg.
TILT, NCT00105235: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

Completed
2
27
US, Canada
Alemtuzumab, Campath, Cyclosporine, Mycophenolate mofetil, CellCept, Tacrolimus, FK-506, Fujimycin, Liver transplant, Immunosuppression withdrawal
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Liver Disease, Liver Transplantation
03/07
03/11
REVERT, NCT00582738: Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Terminated
2
43
RoW
CsA-TAC (standard Treatment), Everolimus
Novartis Pharmaceuticals
Recurrent Hepatitis C
01/10
01/10
NCT00668369: Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Completed
2
34
Europe
Gradual immunosuppression drug withdrawal.
Hospital Clinic of Barcelona
Hepatitis C Virus Infection, Liver Transplantation
09/11
09/11
A-WISH, NCT00135694: Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

Completed
2
275
US
calcineurin inhibitor-based immunosuppression, liver transplant, liver transplantation, corticosteroids, prednisone, immunosuppression withdrawal
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure
09/15
09/15
NCT01903798: A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis

Completed
2
4
US
Mycophenolate mofetil, Prednisolone, Rilonacept
Southern California Institute for Research and Education, University of Southern California, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, VA Long Beach Healthcare System, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcoholic Hepatitis
04/16
04/16

Download Options